These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4160199)

  • 1. [Remarks on the physiological control of nose drops: critical study of the influence of pH; role of the buffer system].
    Grumbach PE; Kapétanidis I; Mirimanoff A; Paley A
    Pharm Acta Helv; 1965 Jul; 40(7):432-40. PubMed ID: 4160199
    [No Abstract]   [Full Text] [Related]  

  • 2. [Physiological testing of nose drops on guinea pig mucosa: temporary and permanent toxic effects].
    Mirimanoff A; Paley A
    Pharm Acta Helv; 1966 Jan; 41(1):25-38. PubMed ID: 4167674
    [No Abstract]   [Full Text] [Related]  

  • 3. [The action of an oral rhinological agent on the nasal mucous membrane (author's transl)].
    Schumann K
    MMW Munch Med Wochenschr; 1974 May; 116(21):1089-92. PubMed ID: 4135042
    [No Abstract]   [Full Text] [Related]  

  • 4. [Adverse effect of long-term use of vasoconstrictive drops on the nasal mucosa].
    Burmeĭster LK; Butule EA
    Vestn Otorinolaringol; 1975; (4):71-3. PubMed ID: 52936
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological responsiveness of the nasal mucosa.
    Jackson RT
    Ann Otol Rhinol Laryngol; 1970 Jun; 79(3):461-7. PubMed ID: 4193454
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of nasal decongestants on the patency of the nose].
    Taniewski M; Walczak W
    Otolaryngol Pol; 1968; 22(5):695-8. PubMed ID: 4179689
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the absorption of decongestive nose-drops-investigation with a radioactive labelled imidazoline-derivate (author's transl)].
    Münzel M; Eichner H
    Laryngol Rhinol Otol (Stuttg); 1975 Nov; 54(11):875-88. PubMed ID: 53769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical experience with the vasoconstrictor action of H 1032 on the nasal mucosa].
    Carta F
    Arch Ital Otol Rinol Laringol Patol Cervicofacc; 1967; 78(4):510-9. PubMed ID: 4180004
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical evaluation of the preparation "Betadrin-Polfa"].
    Klonowski S; Semczuk B; Pomykalski M; Czerwonka R
    Pol Tyg Lek; 1969 Feb; 24(6):209-11. PubMed ID: 4180773
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experience in the use of a local vasoconstrictor, Otrivin--clinical observation by double blind, cross over method and the effect on the nasal mucosa].
    Sugiura S
    Jibiinkoka; 1971 Jan; 43(1):71-86. PubMed ID: 4099381
    [No Abstract]   [Full Text] [Related]  

  • 11. [Daily administration of nose drops can cause chronic nasal congestion].
    Graf P; Hallén H
    Lakartidningen; 1996 Jan; 93(4):259-62. PubMed ID: 8569350
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of different preparations of nasal decongestants on ciliary beat frequency in vitro.
    Deitmer T; Scheffler R
    Rhinology; 1993 Dec; 31(4):151-3. PubMed ID: 7511251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental study of the action of F.H. 107 on the nasal mucosa].
    Guerrier Y; Flottes L; Riu R; Alavoine J
    J Fr Otorhinolaryngol Chir Maxillofac; 1965 May; 14(3):261-93. PubMed ID: 4158746
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experimental studies on the effect of various mucosa decongesting nose drops].
    Knothe J; Aschoff E
    Dtsch Gesundheitsw; 1969 Dec; 24(50):2384-8. PubMed ID: 4193269
    [No Abstract]   [Full Text] [Related]  

  • 15. [Nose drops for treating swelling of the nasal mucosa. Central side effects in young children].
    Bielenberg J
    Med Monatsschr Pharm; 1990 Feb; 13(2):47-8. PubMed ID: 2179693
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of decongestive nosedrops on human respiratory mucosa in vitro.
    Berg OH; Lie K; Steinsvåg SK
    Laryngoscope; 1994 Sep; 104(9):1153-8. PubMed ID: 7520965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nosedrops and ear drops].
    Breuninger H
    HNO; 1971 Mar; 19(3):65-8. PubMed ID: 4101413
    [No Abstract]   [Full Text] [Related]  

  • 18. REPORT ON A NEW TOPICAL NASAL DECONGESTANT.
    FABRICANT ND; FRANK DI; NEFFSON AH
    Eye Ear Nose Throat Mon; 1964 Dec; 43():39-41. PubMed ID: 14234652
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on the pharmacologic influence on the resorption capability of the nasal mucosa in experimental animals].
    Münzel M; Naumann WH
    Arch Klin Exp Ohren Nasen Kehlkopfheilkd; 1970; 196(2):363-6. PubMed ID: 4099745
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostaglandin E1 as a nasal constrictor in normal human volunteers.
    Jackson RT
    Curr Ther Res Clin Exp; 1970 Nov; 12(11):711-7. PubMed ID: 4099967
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.